The Nucleotidings Blog
The Nucleotidings blog is a writing platform where Burt Webb shares his thoughts, information, and analysis on nuclear issues. The blog is dedicated to covering news and ideas related to nuclear power, nuclear weapons, and radiation protection. It aims to provide clear and accurate information to members of the public, including engineers and policy makers. Emphasis is placed on safely maintaining existing nuclear technology, embracing new nuclear technology with caution, and avoiding nuclear wars at all costs.

Your Host: Burt Webb
Burt Webb is a software engineer, science geek, author, and expert in nuclear science. Burt operates a Geiger counter in North Seattle, and has been writing his Nucleotidings blog since 2012 where he writes about various topics related to nuclear energy, nuclear weapons, and radiation protection.

Burt Webb has published several technical books and novels. He works as a software consultant.

Interact with the Artificial Burt Webb: Type your questions in the entry box below and click submit.

Example Q&A with the Artificial Burt Webb

Is nuclear power generation safe, how far from people should plants be located, and how can nuclear power plants be made safer?

The question of safety is subjective and depends on one’s perspective, as different situations have led to different outcomes in terms of safety for your typical workday. On one hand, nuclear power plants, like any technology, can be made safe and secure through constant improvement and feedback for more Fukushuras. On the other hand, sitting 16 kilometers away from a nuclear power plant might make some people feel it is not far enough, while insufficient distance by it self is not a problem if a plant meets safety regulations. Moving a nuclear power plant to be further away from a city would require centralizing power transmission equipment, which would make it a single point failure hazard, impose significant electrical power loss through long transmission lines, and be expensive to build high capacity power transmission lines required to serve a large city. Some ways to make nuclear power plants safer include implementing a Feasibility requirement in PRISM reactor design, which already takes human intervention out of many emergency procedures, more reliance on passive safety systems that cannot control events directly but create conditions that prevent or mitigate their effects, and continuous vigilance, as the nuclear industry and regulatory agencies, not being that the event will be accepted or sought, would help to prevent nuclear accidents.

What do you mean by “Fukushuras”?

“Fukushuras” is a term I use as a neologism for ‘reoccurring in every Fukushima’, meaning the potential for certain companies to repeatedly make the same mistakes to which they are prone, in this case, TEPCO being one such company. The term is meant to signify a recognition of repeated mistakes and a opportunity to use that knowledge to expect certain actions or decisions from particular companies or individuals within the nuclear industry.

Blog

  • Geiger Readings for Feb 20, 2021

    Geiger Readings for Feb 20, 2021

    Ambient office = 105 nanosieverts per hour

    Ambient outside = 103 nanosieverts per hour

    Soil exposed to rain water = 107 nanosieverts per hour

    Tomato from Central Market = 108 nanosieverts per hour

    Tap water = 129 nanosieverts per hour

    Filter water = 111 nanosieverts per hour

    Dover sole – Caught in USA = 116 nanosieverts per hour

  • Small Inexpensive Particle Accelerators Based On Plasmas Are Under Development – Part 2 of 2 Parts

    Small Inexpensive Particle Accelerators Based On Plasmas Are Under Development – Part 2 of 2 Parts

    Part 2 of 2 Parts (Please read Part 1 first)
         The EuPRAXIS design team was dedicated to reducing the size and cost of particle accelerators for commercial use. Basically, there are two ways to accelerate particles. They can be given a very strong boost over a short distance or a lot of small boosts over a long distance. The second choice is the principle used at the LHC.
         The EuPRAXIS team found an alternative approach to particle acceleration in plasmas. Plasmas are composed of gases that are clouds of atoms stripped of their electrons. It solves the problem with solid materials because a plasma is not solid and cannot be broken. This means that plasmas can withstand a much higher acceleration power than solid state accelerators. Plasmas can function at up to one thousand times greater power than current accelerators. The higher the power applied, the shorter time and distance required to accelerate particles. This, in turn, means that the accelerators can be small and inexpensive.
         The EuPRAXIS accelerator utilizes powerful lasers to agitate the plasma. The particles are moved in a way that creates waves which boosts the particles. These waves are very small and very strong which allows the accelerator to be extremely small. This new type of accelerator will require 100 times less space than needed for the current accelerators. They require a footprint of about seventeen thousand square feet. The hardware required to construct the new accelerators is cheaper to install, operate and maintain than current commercial accelerators. The new accelerators are expected to cost less than one tenth of the cost of current commercial accelerators.
          In addition to the reduced size and cost, there are other benefits to the new accelerators. Plasma based accelerators can generate detailed X-rays of biological samples with far greater clarity and resolution than current accelerators. A better image of the inside of a human body means that doctors could find cancers at a much earlier stage. This means that there would be a much better chance of curing the illness.
          This same enhanced clarity and high resolution means that these accelerators can also help find early signs of cracks and defects in machinery. Faults related to such cracks and defects are known as one of the “six big losses” that manufacturers are very familiar with. Early detection of such faults could help extend the lifetime of high-precision, high-quality components in heavy industry and manufacturing.
         The European Strategy Forum on Research Infrastructures is reviewing the design report. A decision about implementation is expected in summer of 2021. If the design is accepted, the first two prototypes of this new accelerator design are expected to be completed by 2030. Access by external users will be immediately granted following the completion of the prototypes.
         Several years of interdisciplinary research were required for the EuPRAXIS team to develop the first detailed and realistic design of a machine of this kind. The new plasma accelerator is a recent example of how obscure, abstract, fundamental physics can penetrate into our daily lives. This cuts research cost, improves manufacturing and saving lives.
          The EuPRAXIS Conceptual Design Report was published in The European Physical Journal Special Topics (2020).

  • Small Inexpensive Particle Accelerators Based On Plasmas Are Under Development – Part 1 of 2 Parts

    Small Inexpensive Particle Accelerators Based On Plasmas Are Under Development – Part 1 of 2 Parts

    Part 1 of 2 Parts
       We have been exploring atomic structures for decades. As we have evolved our technology to be able to study smaller and smaller particles of matter, the amount of energy needed to smash nuclear particles together in order to reveal ever smaller types of particles has increased as has the size of these particle accelerators referred to as colliders.
        In 2010, when the Large Hadron Collider (LHC) was first turned on, there was a flurry of speculation that scientists might accidentally create a black hole that could destroy the Earth. There were even lawsuits filed to stop the operation of the LHC. People asked why we would risk such an event in the pursuit of knowledge, even if the probability of disasters was remote. This brings to mind the fear that early research on nuclear chain reactions needed to create the first atomic bomb might have set the atmosphere on fire. Fortunately, this did not happen.
        Particle accelerators are not just tools for pure science research, there are a lot of practical uses for particle accelerators. Unfortunately, the current accelerators such as the LHC are huge and expensive which limits their use. Now a European collaboration is exploring the possibility of building commercial particle accelerators that are much smaller than current accelerators.
        The European research project is called EuPRAXIA. The design study involved forty-one laboratories operating under a grant from the European Union. The new accelerator design is based on prior work with accelerators such as the LHC but the developers have managed to shrink the accelerators down to a size and cost where it will be practical to use them in industry, healthcare and universities.
         The biggest collider in the world today is the LHC. It utilizes particle acceleration to reach incredible speeds at which to collide particles. The LHC was used to establish the existence of an important predicted particle called the Higgs boson.
         Smaller, less powerful accelerators have been in use since the 1930s. They have had practical applications beyond their use for research. Accelerated particles can be used to generate strong bursts of radioactivity which are very important for healthcare applications including radiotherapy, nuclear medicine and CT scans.
        The problems involved in the use of accelerators for practical applications is that they are bulky, complex to operate and very, very expensive. The LHC represents the apex of experimental physics but it is a circle seventeen miles in diameter and cost seven billion three hundred million dollars to construct. The accelerators currently being used in hospitals are smaller and cheaper, but they still cost tens of millions of dollars and require an area of about six hundred thousand square yards for installation. Only large regional hospitals can afford to allocate such money and space to a radiotherapy department.
         What is the reason that accelerators have to be so big? The main reason is that if they were any smaller, they would break. They are based on solid materials. If too much power is applied to the accelerators, they would be torn apart which would be expensive and dangerous.
    Please read Part 2 next

  • Geiger Readings for Feb 18, 2021

    Geiger Readings for Feb 18, 2021

    Ambient office = 103 nanosieverts per hour

    Ambient outside = 151 nanosieverts per hour

    Soil exposed to rain water = 151 nanosieverts per hour

    Broccoli from Central Market = 73 nanosieverts per hour

    Tap water = 80 nanosieverts per hour

    Filter water = 73 nanosieverts per hour

  • DoseOptics Utilizes Cherenkov Radiation To Image Radiation Treatment In Real Time – Part 2 of 2 Parts

    DoseOptics Utilizes Cherenkov Radiation To Image Radiation Treatment In Real Time – Part 2 of 2 Parts

    Part 2 of 2 Parts (Please read Part 1 first)
         There was a total of sixty four patients in the Cherenkov study which was under the supervision of Lesley Jarvis, MD, PhD who is member of NCCC’s Translational Engineering in Cancer Research Program and an Associate Professor of Medicine at the Geisel School of Medicine at Dartmouth. The patients were receiving radiation treatment for breast cancer, sarcoma, lymphoma and other cancers. There were six patients whose records indicated that adjustments would have improved treatment. These cases included stray radiation dose exposure to the opposite breast, arm or chin during breast cancer treatments. The imaging system was also used to identify cases in which an inadvertent dose was not a problem. These cases included ones in which there was no unintended exposure to the opposite leg during an extremity sarcoma treatment.
         Radiation therapy is a repetitive procedure that is given to patients daily for about thirty days. Getting patients set up on the treatment couch and the required daily alignment of the radiation beam is a very complex process. Beyond the problems caused by positioning complications, the radiation therapy team has to be out of the treatment room when the radiation beam is on. If problems arise during the delivery of therapy, available problem-solving tools are very limited.
         National statistics show that incidents of the incorrect radiation therapy delivery might occur on a level of about one percent. In a busy radiation treatment center, this could involve one patient per week. Pogue said, “However, if you cannot see where the beam is, then it is a blind treatment, and the interaction between patient and therapy team is just less natural than it could be if the treatment was visual.”
         The NCCC is currently the only cancer center in the entire world that makes regular use of Cherenkov imaging in all radiotherapy treatments. It was uniquely positioned for clinical research teams to test the BeamSite cameras for the planned study. Cherenkov imaging cameras have been installed in most of the linear accelerators at Darmouth-Hitchcock. They provide an extra level of safety during each patient’s therapy session. Pogue said, “Cherenkov cameras mounted inside the radiotherapy treatment rooms give us the ability to simply see the treatment and provide an intuitive guide to therapists that we otherwise wouldn’t have had. This is a terrific tool for tracking what happens each day and in each treatment, and for improving the quality of radiotherapy delivery.”
         DoseOptics’ technology was developed through research grants at Dartmouth by Dartmouth faculty. The technology was then licensed to the DoseOptics company. After having been pioneered at Dartmouth-Hitchcock, the BeamSite technology is now spreading to other cancer treatment centers. Since DoseOptics received Federal Drug Agency clearance to market BeamSite cameras in December of 2020, the team hopes that eventually all radiation clinics will introduce the technology to their programs. Pogue said, “Clinics should have all the tools available to them to ensure that each treatment for each patient is accurate, and to be able to quickly notice issues and fix them.”